VNDA - Vanda Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5741.15M
Enterprise Value 3542.7M
Trailing P/E N/A
Forward P/E 125.09
PEG Ratio (5 yr expected) 1-2.35
Price/Sales (ttm)4.49
Price/Book (mrq)4.98
Enterprise Value/Revenue 33.29
Enterprise Value/EBITDA 6-38.99

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin -9.43%
Operating Margin (ttm)-10.24%

Management Effectiveness

Return on Assets (ttm)-5.08%
Return on Equity (ttm)-11.85%

Income Statement

Revenue (ttm)165.08M
Revenue Per Share (ttm)3.69
Quarterly Revenue Growth (yoy)15.80%
Gross Profit (ttm)147.24M
EBITDA -13.92M
Net Income Avi to Common (ttm)-15.57M
Diluted EPS (ttm)-0.35
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)143.41M
Total Cash Per Share (mrq)3.16
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.41
Book Value Per Share (mrq)2.92

Cash Flow Statement

Operating Cash Flow (ttm)-1.98M
Levered Free Cash Flow (ttm)27.65M

Trading Information

Stock Price History

Beta -0.06
52-Week Change 3-4.26%
S&P500 52-Week Change 310.35%
52 Week High 320.30
52 Week Low 311.90
50-Day Moving Average 316.77
200-Day Moving Average 315.66

Share Statistics

Avg Vol (3 month) 3749.98k
Avg Vol (10 day) 3392.64k
Shares Outstanding 550.94M
Float 38.19M
% Held by Insiders 12.70%
% Held by Institutions 180.63%
Shares Short 31.7M
Short Ratio 32.72
Short % of Float 33.90%
Shares Short (prior month) 31.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A